Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Liver Int. 2016 Jul 6;36(12):1783–1792. doi: 10.1111/liv.13177

Figure 2.

Figure 2

Predicted upstream activation of TGF-β3 (A) and IL-10 (B) pathways. Shown are ratios of end of treatment (EOT, week 20) over pre-treatment (PRE) gene expression, with red representing increased post-treatment gene expression, blue representing decreased gene expression, and ratio indicated in each field. TGF-β3 and IL-10 pathways had an Ingenuity Pathway Analysis (IPA) activation Z-scores 2.4 and 2.2, respectively.